Company / EPS (Diluted)
Moderna EPS (Diluted) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$12.33
FY2025
5-year range
-$12.33 / $28.29
FY2021-FY2025
Trend
-161.3%
vs FY2024
Sector context
#201 of 204
Health Care
What the data says
Among 204 Health Care companies, Moderna is in the bottom 1% for eps (diluted). EPS (Diluted) has fluctuated over the past 8 years, ranging from $-12.33 in FY2025 to $28.29 in FY2023.
Based on SEC 10-K filings.
-12.33 in FY2025.
Declined from $28.29 to $-12.33 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 204This company -$12.33 Sector average -$0.89
▼
-1277.7% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 161.3% year-over-year.
- Ranks #201 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$12.33 | -161.3% |
| FY2024 | $20.12 | -28.9% |
| FY2023 | $28.29 | +1543.4% |
| FY2022 | -$1.96 | -26.5% |
| FY2021 | -$1.55 | +68.7% |
| FY2020 | -$4.95 | -18.4% |
| FY2019 | -$4.18 | -10.3% |
| FY2018 | -$3.79 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026